Receiving a diagnosis of HER2+ and ER+ breast cancer that is either metastatic (has spread to other organs) or locally advanced (cannot be surgically removed) is a life-altering moment. It brings a unique set of challenges because this specific subtype of cancer is “driven” by two different fuel sources. However, while the diagnosis is serious, the medical landscape for HER2+/ER+ cancer has been revolutionized in recent years. Understanding the synergy between these receptors and the breadth of modern treatment can transform overwhelming news into a structured plan of action.
Understanding HER2+ and ER+ Breast Cancer
To understand HER2+ and ER+ breast cancer, it helps to think of the cancer cells as having multiple “engines” that drive their growth.
- ER+ (Estrogen Receptor Positive): The cancer cells have receptors that allow them to use the hormone estrogen as fuel. When estrogen binds to these receptors, it signals the cell to divide and multiply.
- HER2+ (Human Epidermal Growth Factor Receptor 2): This refers to a protein on the outside of many breast cells. In HER2+ cancer, the cells have an overabundance of these receptors (overexpression), which sends constant, aggressive signals to the cell to grow uncontrollably.
When a patient is positive for both, the cancer is often more complex because the ER and HER2 pathways can “talk” to each other. Sometimes, if one pathway is blocked by medicine, the cancer tries to compensate by revving up the other. This is why a dual-targeted approach is the gold standard for treatment.
You May Also Like
Signs that Cancer Has Spread
Detecting signs that cancer has spread beyond the breast tissue is crucial. Symptoms may include persistent cough, bone pain, unexplained weight loss, headaches, or neurological symptoms like confusion or seizures.
Recognizing these symptoms early allows your oncology team to adjust your systemic therapy quickly.
- Bones: Persistent, aching pain that doesn’t go away with rest or worsens at night.
- Lungs: A dry, nagging cough or shortness of breath during daily activities.
- Liver: Jaundice (yellowing of the skin/eyes), abdominal swelling, or significant loss of appetite.
- Brain: New, frequent headaches, blurred vision, or changes in balance and coordination.
However, it’s important to note that these symptoms can be caused by other conditions, so consulting with your healthcare provider for proper evaluation is essential.
You May Also Like
Navigating the Diagnosis
If your healthcare provider has confirmed that your HER2+ and ER+ breast cancer has spread or cannot be surgically removed, it’s crucial to work closely with your healthcare team to develop a comprehensive treatment plan.
This plan may include a combination of treatments tailored to your specific situation.
Treatment Options
- Targeted Therapy: Targeted therapies target HER2-positive cancer cells, slowing or stopping their growth.
- Hormone Therapy: Hormone therapy blocks the effects of estrogen on cancer cells, reducing the risk of cancer recurrence.
- Chemotherapy: Chemotherapy may be used to kill cancer cells throughout the body, particularly if the cancer is aggressive or has spread to distant organs.
- Radiation Therapy: Radiation therapy may be used to target specific areas of cancer spread, such as bone metastases, to relieve pain and control the growth of cancer cells.
5 Reasons to Try a Clinical Trial for HER2+ and ER+
If you’re facing HER2-positive, ER-positive breast cancer that has spread or can’t be surgically removed, participating in a clinical trial could be a game-changer. Here’s why:
Exploring New Options
Clinical trials offer access to cutting-edge treatments that may not be available otherwise. This gives you the opportunity to try an experimental drug that could enhance your current treatment plan.
Personalized Care
By joining a trial, you become part of a research community focused on improving treatments for your specific type of breast cancer. This means you’ll receive personalized care and attention from a team of experts dedicated to your well-being.
Active Involvement in Your Treatment
Trials empower you to take an active role in your treatment journey. You’ll work closely with your healthcare team to monitor your progress, which can be empowering and motivating.
Potential Health Benefits
While there are no guarantees, participating in a trial could lead to improved health outcomes, offering you a better quality of life.
Contribution to Future Treatments
By participating in a trial, you’re contributing to the advancement of medical knowledge. Your experience and feedback could help shape future treatments for HER2-positive, ER-positive breast cancer, benefiting others in the future.
Remember, joining a clinical trial is a personal decision that should be made in consultation with your healthcare team. They can provide you with all the information you need to make an informed choice about your treatment options.
HER2+ and ER+ breast cancer that has spread or cannot be surgically removed presents unique challenges, but with the right support and treatment, you can live a fulfilling life. By staying informed, seeking support, and working closely with your healthcare team, you can navigate this journey with strength and resilience.
